Log In
Print
BCIQ
Print
Print this Print this
 

fostamatinib disodium (formerly R788, Tamatinib fosdium)

Also known as: FosD, fostamatinib (formerly R406)

  Manage Alerts
Collapse Summary General Information
Company Rigel Pharmaceuticals Inc.
DescriptionOral spleen tyrosine kinase (SYK) inhibitor
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionSyk kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIdiopathic thrombocytopenic purpura (ITP)
Indication DetailsTreat idiopathic thrombocytopenic purpura (ITP); Treat refractory idiopathic thrombocytopenic purpura (ITP)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today